Inspire Medical Systems Operating Income 2017-2024 | INSP

Inspire Medical Systems operating income from 2017 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Inspire Medical Systems Annual Operating Income
(Millions of US $)
2023 $-40
2022 $-48
2021 $-40
2020 $-56
2019 $-35
2018 $-20
2017 $-16
2016 $-17
Inspire Medical Systems Quarterly Operating Income
(Millions of US $)
2024-03-31 $-15
2023-12-31 $9
2023-09-30 $-13
2023-06-30 $-17
2023-03-31 $-19
2022-12-31 $-0
2022-09-30 $-17
2022-06-30 $-14
2022-03-31 $-16
2021-12-31 $-2
2021-09-30 $-10
2021-06-30 $-13
2021-03-31 $-16
2020-12-31 $-7
2020-09-30 $-10
2020-06-30 $-23
2020-03-31 $-16
2019-12-31 $-9
2019-09-30 $-9
2019-06-30 $-8
2019-03-31 $-9
2018-12-31 $-5
2018-09-30 $-5
2018-06-30 $-6
2018-03-31 $-5
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-4
2017-03-31 $-4
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.986B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.069B 20.90
Axonics (AXNX) United States $3.440B 0.00
10x Genomics (TXG) United States $3.097B 0.00
IRhythm Technologies (IRTC) United States $3.080B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.900B 0.00
Enovis (ENOV) United States $2.801B 20.76
Azenta (AZTA) United States $2.782B 156.36
Hims & Hers Health (HIMS) United States $2.640B 0.00
Privia Health (PRVA) United States $2.144B 119.80
Schrodinger (SDGR) United States $1.652B 0.00
Omnicell (OMCL) United States $1.383B 47.81
Phreesia (PHR) United States $1.205B 0.00
Standard BioTools (LAB) United States $0.696B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Definitive Healthcare (DH) United States $0.627B 0.00
Talkspace (TALK) United States $0.477B 0.00
Clover Health Investments (CLOV) United States $0.406B 0.00
Health Catalyst (HCAT) United States $0.378B 0.00
Pulmonx (LUNG) United States $0.326B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.306B 0.00
Butterfly Network (BFLY) United States $0.215B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Outset Medical (OM) United States $0.159B 0.00
American Well (AMWL) United States $0.139B 0.00
TruBridge (TBRG) United States $0.129B 7.07
MSP Recovery (LIFW) United States $0.121B 0.00
Augmedix (AUGX) United States $0.109B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.078B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.055B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Movano (MOVE) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00